Qube Research & Technologies LTD Verastem, Inc. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.33 - $10.44 $32,627 - $1.03 Million	-98,872 Reduced 89.06%	12,142 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $17,861 - $216,671	19,415 Added 21.2%	111,014 $94,000
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $93,430 - $167,626	91,599 New	91,599 $106,000
Q1 2022 May 09, 2022	SELL	$1.06 - $2.1 $178,421 - $353,476	-168,322 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$2.05 - $3.2 $345,060 - $538,630	168,322 New	168,322 $345,000
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $168,203 - $269,523	-66,222 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $170,190 - $321,176	66,222 New	66,222 $270,000
Q3 2020 Nov 12, 2020	SELL	$1.11 - $1.68 $114,758 - $173,688	-103,386 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $174,722 - $434,221	103,386 New	103,386 $178,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.